Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideABTAbbott Laboratories
FinDog View：Neutral
SYKStryker Corporation
FinDog View：Bearish
| Metric | ABT | SYK |
|---|
| Close | 106.20 | 291.86 |
| Market Cap | $184B | $114B |
| 1M | +7.46% | +5.98% |
| P/E (TTM) | 39.1 | 30.3 |
| Forward P/E | 17.6 | 17.0 |
| P/E 5-Yr Percentile | 99 | 3 |
| P/S | 3.8 | 4.4 |
| P/B | 3.6 | 4.7 |
| Dividend Yield | 1.98% | 1.02% |
| Latest Quarter Revenue | $11.2B | $6.5B |
| Revenue YoY | +7.8% | +7.6% |
| Gross Margin | 56.2% | 65.2% |
| Latest Quarter EPS | 0.61 | 1.96 |
| Avg Post-Earnings Move | ±1.6% | ±4.3% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.71% | 1.17% |
| 90-Day Net Insider Buying | −$46.9M | −$118M |
ABT · Revenue, Last 8 Quarters ($B)
SYK · Revenue, Last 8 Quarters ($B)
